Clinical Trials Browser

Phase 2 × Breast Neoplasms × Drug Screening Assays, Antitumor × Clear all

NCT00003253 2013-12-19

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Breast Neoplasms, Male